#16 How drug safety can help fight resistant bugs – Jean Marie Vianney Habarugira & Albert Figueras

#16 How drug safety can help fight resistant ...

Up next

#44 Rethinking medical device safety, part 2 – Omar Aimer

Send a text message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can put patients at risk. In this two-part episode, Omar Aimer, President of ISoP and form ...  Show more

#43 Rethinking medical device safety, part 1 – Omar Aimer

Send a text message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can leave patients vulnerable. In this two-part episode, Omar Aimer, president of ISoP and ...  Show more

Recommended Episodes

Can we reverse rising drug deaths?
Inside Health

Drug-related deaths are at their highest levels in England and Wales since records began 30 years ago.Scotland has had the highest number of drug deaths in Europe for at least seven years. And the UK has even seen opioid-related deaths surpass the number of people dying in road t ...  Show more

The Medical Matchmaking Machine
Radiolab

As he finished his medical school exam, David Fajgenbaum felt off.  He walked down to the ER and checked himself in.  Soon he was in the ICU with multiple organ failure.  The only drug for his condition didn’t work. He had months to live, if that.  If he was going to survive, ...

  Show more

How Can We Reduce Unnecessary Lab Testing?
Faces of Digital Health

Laboratory tests provide doctors with crucial information for diagnosis, monitoring disease progression, evaluating organ function, assessing risk factors for diseases and more. Laboratory testing can be reassuring, however, it is often deemed unnecessary. In this short episode r ...  Show more

Tackling bias in health
People Fixing the World

Bias in the way medical research is carried out means that new medicines for diseases such as cancer – as well as the tools used to diagnose patients with some conditions – are disproportionally tested on people of European heritage. This can lead to those not represented in the ...  Show more